RxAll

📍 New Haven, United States🗓 Founded 2016👥 26 employees💰 Last funded Feb 2020
RxAll™ is a digital infrastructure platform for healthcare. We enable on-demand access to high quality medicines at manufacturer/wholesale price to hospitals, pharmacies and patients from our curated network of high quality wholesalers and pharma companies. We solve $1.25T problem of access to affordable safe drugs. Our tech stack includes a proprietary instant drug testing platform- RxScanner™- that helps our sellers authenticate the medicines they sell. We also have the RxPOS™ that helps our sellers manage and sell inventory in store and online through our RxDelivered™ marketplace. Further, we have our embedded fintech RxPay™ that helps finance invoices for buyers on our platform ensuring availability and affordability of high quality medicines from our pharma company and wholesaler partners to our B2B2C customers. Our vision is to enable universal access to high quality medicines at the lowest prices to all humans across the world - starting with Africa.
3
Total investors
2
Early stage
1
Mid stage
0
Late stage
2016
Founded
Investor geography2 countries
Norway
2
United States
1
Investor activity2018–2020 · investors recorded per year
2018220201
Recent (last 2y)Earlier
Frequently asked questions
Who invested in RxAll?
RxAll has 3 investors on record on gritt.io, including 2 early-stage backers, 1 mid-stage.
When did RxAll last raise funding?
The most recent investment in RxAll recorded on gritt.io was in February 2020.
When was RxAll founded?
RxAll was founded in 2016.
What industry is RxAll in?
RxAll operates in Internet Marketplace Platforms. Find similar Internet Marketplace Platforms investors on gritt.io.
Where is RxAll based?
RxAll is headquartered in New Haven, United States.